Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Am J Clin Oncol. 2018 Apr;41(4):396–401. doi: 10.1097/COC.0000000000000289

Table 2. Grade 2+ Pulmonary Adverse Events within 12 months.

Observation<br>(n=13) Captopril<br>(n=7)
Follow-up Time (months)
 Median 16.3 17.8
 Range 3.4 – 30.0 4.0 – 27.2
Time to Grade 2+ Pulmonary adverse event(Radiation)
 Median 2.93 3.29
 Range 1.9 – 7.9 3.29 – 3.29
Time to Grade 2+ Pulmonary adverse event(Any modality)
 Median 2.73 4.77
 Range 1.9 – 7.9 3.3 – 6.7
Events % Events %

Grade 2+ Pulmonary adverse event<br>(Radiation) 3 23 1 14
Grade 2+ Pulmonary adverse event<br>(Any modality) 5 39 4 57

CTCAE v3.0